AbbVie Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 1 N Waukegan Rd, North Chicago, Illinois (IL) 60064, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3009751352 · DUNS 078458370
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2026-04-27
- NAIBioresearch Monitoring2026-04-02
- NAIBioresearch Monitoring2025-08-21
- NAIBioresearch Monitoring2025-06-12
- NAIBioresearch Monitoring2024-04-19
- VAIDrug Quality Assurance2023-01-31
- NAIBioresearch Monitoring2022-10-06
- VAIBioresearch Monitoring2021-12-15
- NAIBioresearch Monitoring2019-02-15
- NAIBioresearch Monitoring2018-11-16
- VAIBioresearch Monitoring2018-07-02
- VAIDrug Quality Assurance2017-12-15
- NAIBioresearch Monitoring2016-02-04
- NAIDrug Quality Assurance2015-12-16
- NAIDrug Quality Assurance2014-11-18
- NAIBioresearch Monitoring2014-09-29
- NAIBioresearch Monitoring2014-06-06
- VAIDrug Quality Assurance2013-12-13
- NAIDrug Quality Assurance2013-09-04
- NAIDrug Quality Assurance2013-04-25
Drugs this plant is listed as making
0 distinct drugs across 0 products name this site in their FDA label.
No drug labels currently list this site.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.